BEIJING, June 30, 2014 /PRNewswire/ — Walmart has agreed to sponsor the translation of a Food Fraud Prevention online course to the Mandarin language. The course was developed by Dr. John Spink, Professor at Michigan State University (MSU) and Director of the University’s Food Fraud Initiative. Dr. Spink, a recognized expert in this area, has joined Walmart in their efforts to help customers, regulators, suppliers and retailers increase public awareness of food fraud prevention in China and prevent food fraud through joint efforts in the market.

MSU’s first Food Fraud Prevention Overview was originally conducted in May of 2013 and it has only been offered in English. Since its debut, the massive open online course (MOOC) has seen over 800 participants from 48 countries take in the free course. Following the first MOOC, there has been great interest in follow-up courses and translation into other languages. The Walmart sponsorship of the first language translation of the MOOC into Mandarin is a critical next step in protecting against food fraud and improving the global food supply chain.

This two-week MOOC is offered free to anyone, anywhere, who has Internet access. The first Mandarin version of the two-week course will be offered in two sections, on August 5 and August 12. It is especially targeted to be a tool to help food companies in China further strengthen their food fraud prevention and surveillance programs.

Participants of the MOOC will gain important insights into the reasons food fraud continues to be a major issue in the global supply chain. The course will draw on a wide range of current experience and expertise, infusing many real-world applications and problem-solving exercises that will provide a framework for success in the future.

Frank Yiannas, Vice President of Food Safety for Walmart said, “At Walmart, we take the issue of food fraud very seriously. Because prevention of food fraud is a shared responsibility and education is a key to deterrence, Walmart is delighted to be able to help Michigan State University make the course more broadly available to regulatory officials, industry professionals, consumers and other stakeholders in China.”  

Dr. Spink said, “We are grateful for forwardthinking companies like Walmart who are working, and investing in, improving the safety of the world’s foods.” He elaborated that, “When we rapidly expand the education and awareness building at this early stage in the development of the science, we can more efficiently establish a starting point and trajectory of our actions.”

“Food fraud has been recognized as a common challenge not only for retailers but also the whole supply chain, Walmart China Chief Compliance Office Paul Gallemore said. “As the largest retailer in the world, Walmart intends to leverage global food safety expertise and best practices to help our suppliers address the problem together in order to provide even greater assurance of food product quality, authenticity and safety to our customers.”

The retailer recently announced they are continuing to invest heavily in food safety for China with their total investment for 2013, 2014 and 2015 reaching 300 million Yuan. A portion of this investment has been heavily focused on supplier training and management. Walmart is helping suppliers understand and comply not only with China’s regulations, but the company’s extensive and rigorous food safety policies. Meanwhile, the company will perform additional testing and tougher standards for suppliers in 2014, increasing DNA testing on meat products by 100 percent and facility audits and inspections of primary producers by more than 30 percent from 2013. Walmart China has also taken a zero-tolerance policy on food fraud.

Read More

NEW YORK, June 26, 2014 /PRNewswire/ — The Special Master in the Argentina Debt Litigation, Daniel A. Pollack, issued the following statement today: “Counsel for the parties met with me yesterday for several hours, and have also communicated with me telephonically over the course of the last 48 hours. No resolution has been reached. The parties, through their counsel, have agreed to keep the substance of our discussions confidential in order to facilitate the possibility of a future resolution. No further elaboration will be made on this statement.”

Read More

AMSTERDAM, June 25, 2014 /PRNewswire/ — Today Atradius Collections releases the new edition of the International Debt Collection Handbook explaining the different stages of amicable settlement, financial regulations around collections, legal proceedings and insolvency procedures. The handbook is useful for credit managers confronted with the diversity and complexity of country-specific debt collections, now covering 38 countries, including Chile, Ukraine and South Africa. 

International debt collection and country-specific legal systems create challenges that affect every business. The International Debt Collection Handbook has proven to be an invaluable, highly demanded product for decision-makers in the collections and credit management industry. It gives readers an overview of foreign debt collection practices at country level. Rudi De Greve, Global Operations Director at Atradius Collections, explains: “The amicable collection route should always be the preferred option, however, taking legal actions is sometimes required. In either case, the key is to respect local ethics and the law. Only with local expertise can businesses ensure they are following a professional and successful approach.”

With insolvency levels peaking in many countries, selecting the right approach to debt collection has become an even more important factor for maintaining cash flow. Moreover, payment delays are common and insolvency risks remain high, both negatively impacting cash flow. A complex payment procedure in many cases results in foreign payment delays.

As a global market player, Atradius Collections acknowledges the importance of understanding local needs and being able to operationalize at a local level as the key to successful debt collection. Therefore Atradius Collections is planning on expanding its geographical reach into new markets, strengthening its global market position.

About the International Debt Collection Handbook 

Since its launch in 2008, the International Debt Collections Handbook has undergone constant update and expansion to provide decision makers with the most recent information. Rudi De Greve, Global Operations Director at Atradius Collections: “The handbook consists of information gathered by local experienced collectors and lawyers, making it a trusted international debt collections navigator.”

The full International Debt Collection Handbook is available for download at http://www.atradiuscollections.com/global/updates-publications/international-debt-collections-handbook.html

About Atradius Collections 

Atradius Collections, a business unit of Atradius Group, provides efficient, quick and flexible solutions to recovering domestic and international trade debts. With 20 offices and an extensive network of collections specialists and lawyers worldwide, Atradius Collections serves more than 14,500 customers. Over 85 years of global credit management industry experience uniquely positions Atradius Collections as a worldwide leader in business-to-business trade invoice collections services. Please visit http://www.atradiuscollections.com for more information.

Further information:
Iris Graatsma
Iris.Graatsma@atradius.com
Telephone: +31-20-553-3139
http://www.atradiuscollections.com
http://www.linkedin.com/company/atradius-collections
http://www.twitter.com/AtradiusCollect

Read More

HONG KONG, June 17, 2014 /PRNewswire/ — The Financial Times today announces the winners of the inaugural FT Asia-Pacific Innovative Lawyers programme, in partnership with RSG Consulting, a specialist legal research and strategy agency, and sponsored by Integreon, a leading global provider of outsourced legal, document, research and business support. The event builds on the success of the long-running Innovative Lawyers awards in the U.S. and Europe which annually recognise the most entrepreneurial lawyers, law firms, and legal departments.

Photo – http://photos.prnewswire.com/prnh/20140616/118646

The top honours were awarded to William Liu (Linklaters), named Most Innovative Lawyer; King & Wood Mallesons, named Most Innovative Asia-Pacific Law Firm; Freshfields Bruckhaus Deringer, named Most Innovative International Law Firm; and Tencent, named Most Innovative In-House Legal Team. The ceremony was hosted in Hong Kong.

The FT Innovative Lawyers Programme is based on a rigorous research process that includes expert analysis, market surveys and hundreds of interviews with legal professionals. The awards cover legal professionals and departments across Australia, mainland China, Hong Kong, India, Japan, Malaysia, Singapore and South Korea.

“Our congratulations to all of the 2014 winners and nominees from this year’s FT Asia-Pacific Innovative Lawyers Awards,” said Robert Gogel, CEO of Integreon. “Innovation has long-been a focus of Integreon as we seek to delight our law firm and corporate clients by transforming how legal services are delivered. Our partnership with the FT and RSG aligns well with our focus on innovation by encouraging innovative practices among our colleagues, partners and others across the global legal community.”

“We’re delighted to introduce the FT’s well established Innovative Lawyers report to one of the most dynamic legal environments in the world,” said David Pilling, Asia managing editor of the FT. “As the region’s business practices change to adapt to a shifting landscape, the role of lawyers and legal frameworks must equally evolve. This report celebrates the best of these strategies.”

The complete list of 2014 award winners includes:

  • Legal Innovation in Finance (Real Estate): Kim & Chang
  • Innovation in Corporate Law (International): Slaughter and May
  • Innovation in Corporate Law (Asia-Pacific):
    Joint Winners: AZB & Partners; Bae, Kim and Lee
  • Legal Innovation in TMT: Sullivan & Cromwell
  • Innovation in Finance Law (Asia-Pacific): King & Wood Mallesons
  • Innovation in Finance Law (International):
    Joint Winners: Linklaters; Skadden, Arps, Slate, Meagher & Flom
  • Legal Innovation in an IPO: Davis Polk & Wardwell
  • Innovation in Corporate Strategy (Asia-Pacific): ZICOlaw
  • Innovation in International Strategy: Allen & Overy
  • Most Innovative ASEAN Law Firm: WongPartnership
  • Most Innovative Australian Law Firm: Gilbert + Tobin
  • Most Innovative Indian Law Firm: Nishith Desai Associates
  • Most Innovative Lawyer: William Liu, Linklaters
  • Most Innovative In-house Legal Team: Tencent
  • Most Innovative Law Firm (Asia-Pacific): King & Wood Mallesons
  • Most Innovative Law Firm (International): Freshfields Bruckhaus Deringer

The themes and winners from this year’s programme are also summarized in the FT Asia-Pacific Innovative Lawyers 2014 report. The FT’s U.S. and European reports and awards are scheduled for late 2014.

About the Financial Times:

The Financial Times, one of the world’s leading business news organisations, is recognised internationally for its authority, integrity and accuracy. Providing essential news, comment, data and analysis for the global business community, the FT has a combined paid print and digital circulation of 665,000 (Deloitte assured, Q1, 2014). Mobile is an increasingly important channel for the FT, driving 60 per cent of subscriber consumption, 45 per cent of total traffic and 20 per cent of new digital subscriptions. FT education products now serve 37 of the world’s top 50 business schools.

About RSG Consulting:

RSG was founded in 2001 to give strategy and innovation consulting advice to the international legal profession. Its evidence-based approach includes creating unique thought-leadership projects for clients and independent studies into the future of law and emerging legal markets. The company specializes in rating and ranking lawyers, and its assessment methodologies have wide application particularly in helping law firms differentiate themselves. RSG also runs the Innovative GC Club, an independent forum for in-house lawyers to exchange ideas. It has partnered with the FT on the Innovative Lawyers programme since its inception in 2005.

About Integreon:

Integreon is a trusted, global provider of award-winning legal, document, research and business support solutions to leading law firms, corporate legal departments, financial institutions and professional services firms. Around the globe, Integreon’s 2,200 Associates support more than 250 clients in areas such as market and competitive intelligence, discovery, legal process outsourcing (LPO), operating model transformation and back office redesign. Integreon also excels in business support services such as IT, document processing, finance and HR. With our unrivaled outsourcing experience and industry-leading onshore and offshore capabilities, clients increasingly rely on Integreon to provide value-added solutions and meet their needs in a demanding business environment. Integreon has won more than 40 industry awards over the past five years and supports its global client base from 12 delivery centres across the US, UK, India, Philippines, South Africa and China.

For more information about Integreon’s extensive range of services, please visit www.Integreon.com and follow Integreon on Twitter: @Integreon.

Logo – http://photos.prnewswire.com/prnh/20130423/NY99594LOGO

Read More

BOLOGNA, Italy, June 12, 2014 /PRNewswire/ —

Normix® is the only authorized Gastrointestinal antibiotic based on Rifaximin-alpha. No generic version is allowed.

With the judgment entered last April 18, the district court of Milan, Italy the court having original jurisdiction on the matter -denied a request from generic manufacturers to declare Alfa Wassermann’s patents on Rifaximin polymorphs invalid. Instead, the court upheld Alfa Wassermann’s claim, asserting the Rifaximin-alpha patent and prohibiting any further counterfeit production, advertising and marketing. The announcement is made by Alfa Wassermann, the Bologna-based Italian pharmaceutical multinational that developed Rifaximin-alpha, marketed under the trade name Normix® in Italy, Xifaxan®, Flonorm®, Rifacol®, Spiraxin® and other trade names in other countries. Approved in 34 countries including the US, Rifaximin-alpha is an oral gut-selective antibiotic indicated for most bacterial diarrheas, including travelers’ diarrhea, and other gastrointestinal (GI) disorders. Recently, Rifaximin-alpha was also approved for Hepatic Encephalopathy (HE) in the US and in Europe.

(Logo: http://photos.prnewswire.com/prnh/20140612/690926 )

“We welcome the court decision that has confirmed the uniqueness of Rifaximin-alpha, which is Alfa Wassermann R&D’s most prestigious product and one of the top selling Italian medicines in the US,” said Andrea Golinelli, Chief Strategy Officer, Alfa Wassermann. “The court ruling is a landmark decision for the protection of intellectual property (IP) and the recognition of its crucial value for pharmaceutical R&D and innovation. Without IP protection no scientific innovation nor progress to improve people’s health is possible.” concluded Golinelli.

Alfa Wassermann

Alfa Wassermann is an international Italian pharmaceutical Group with a sixty-year tradition in R&D, production and distribution of medicines of primary importance for people’s health. Its medicines have taken Alfa Wassermann to a leading position in a number of medical areas including Gastroenterology, Vascular medicine, Orthopedics, Rheumatology and Gynecology.

The Group is headquartered in Bologna, Italy, which is also the location of its long-standing R&D facilities. The Group’s international division is in Milan. The Group’s production facilities in Alanno (Pescara, Italy) are some of Europe’s most technologically advanced and make 50 million packaged items annually.

Alfa Wassermann operates globally through 12 subsidiaries in as many world markets. The Group employs 1,400 people and markets products in over 60 countries. In 2013 Alfa Wassermann consolidated sales aggregated to some 400 million euro.

Alfa Wassermann R&D’s most successful product is Rifaximin-alpha, an oral antibiotic for gastrointestinal disorders that is the market leader in Italy, but is also available in many other world countries, including the US. Rifaximin-alpha approval by the US Food and Drug Administration (FDA) has been a highly prestigious recognition for a medicine that is the fruit of Italian R&D.

For further information please visit http://www.alfawassermann.com

Media contact:
Angela Del Giudice
+39-06-6788870
a.delgiudice@vrelations.it

Read More

CLEVELAND, June 12, 2014 /PRNewswire/ —

IN THE COURT OF COMMON PLEAS
CUYAHOGA COUNTY, OHIO

ALFRED STRAUS, Derivatively on Behalf of Nominal
Defendant Eaton Corporation, plc, and on Behalf of
Nominal Defendant Eaton Corporation,

Plaintiff,

Case No.: CV 11 748467

v.

Judge: John P. O’Donnell

MICHAEL J. CRITELLI, ALEXANDER M. CUTLER,
NET C. LAUTENBACH, DEBORAH L. McCOY,

GREGORY R. PAGE, CHARLES E. GOLDEN,
ARTHUR E. JOHNSON, TODD M. BLUEDORN,
GEORGE S. BARRETT, LINDA A HILL, GERALD B.
SMITH, VICTOR LEO, MARK MCGUIRE, TARAS
SZMAGALA, ERNIE GREENE, JOHN R. MILLER,
VICTOR A. PELSON, and GARY L. TOOKER,

SUMMARY NOTICE OF

Defendants,

PENDENCY AND

PROPOSED

and

SETTLEMENT OF

SHAREHOLDER

EATON CORPORATION, plc, and EATON
CORPORATION

DERIVATIVE ACTION

Nominal Defendants.

TO: ALL FORMER AND CURRENT RECORD HOLDERS AND BENEFICIAL OWNERS OF COMMON STOCK OF EATON CORPORATION (“COMPANY”) OR EATON CORPORATION PLC (“PLC”) AS OF JUNE 6, 2014 (“STOCKHOLDERS”).

YOU ARE HEREBY NOTIFIED, pursuant to an Order of the Cuyahoga County, Ohio Court of Common Pleas that a proposed settlement has been reached in this putative shareholder derivative action.

A hearing will be held on July 23, 2014, at 1:30 p.m., before the Honorable John P. O’Donnell in Courtroom 18-D at the Cuyahoga County Court of Common Pleas, 1200 Ontario Street, Cleveland, Ohio 44113‑1678, for the purpose of considering, among other things: (i) whether the proposed settlement will be approved by the Court pursuant to the terms of the Stipulation and Agreement of Settlement (“Stipulation”); (ii) whether the Court should enter a judgment dismissing Plaintiff’s Complaint with prejudice and on the merits, including and all claims which arise out of or are related to the facts and/or circumstances set forth in Complaint; and (iii) whether the Court should approve the award to be made to Plaintiff’s Counsel for Plaintiff’s attorney fees, expenses, costs, and an incentive payment to Plaintiff, up to a total of six million dollars ($6,000,000). The Court has reserved the right to reschedule the hearing without further notice.

Your rights as a Stockholder may be affected by this action and the proposed settlement. Additional details regarding this action, including the Notice of Pendency and Proposed Settlement of Shareholder Derivative Action (“Notice”), are available at http://www.weismanlaw.com. You may also contact a representative of Plaintiff’s Counsel, Weisman, Kennedy & Berris Co., L.P.A., 1600 Midland Building, 101 Prospect Avenue, W., Cleveland, Ohio 44115, telephone 800-475-1189 or 216-781-1111, or Strauss Troy Co., LPA, 150 East Fourth Street, Cincinnati, Ohio 45202-4018, telephone 513‑621-2120, for further information.

If you are a current Stockholder, you may have the right to object to any aspect of the Settlement and may appear in person or through counsel at the hearing. Stockholders who have no objection to the proposed settlement need not take any further action. Any objections to the settlement, including Plaintiff’s Counsel’s request for attorney fees, expenses, costs, and an incentive payment to Plaintiff, must be filed and served, in accordance with the procedures set forth in the Notice, no later than July 14, 2014.

IF YOU CHOOSE TO OBJECT, YOU MUST FOLLOW THE PROCEDURES SET FORTH IN THE NOTICE OR YOU WILL NOT BE HEARD, AND NO PAPERS, BRIEFS, OR OTHER DOCUMENTS BY YOU WILL BE RECEIVED AND CONSIDERED BY THE COURT.

Any Person who fails to object or otherwise request to be heard in the manner prescribed in the Notice will be deemed to have waived the right to object to any aspect of the settlement (including the right to appeal) or to request to be heard at the hearing, and will be forever barred from raising such objection or request in this or any other related action or proceeding.

PLEASE DO NOT CONTACT THE COURT OR THE CLERK’S OFFICE ABOUT THIS NOTICE.

Dated: June 6, 2014

BY ORDER OF THE CUYAHOGA
COUNTY, OHIO COURT OF COMMON
PLEAS

Read More